This is the authors' abstract. We don't add key points for this paper.
BACKGROUND 53 plays a key role in malignant transformation of cervical epithelium. Bcl-2 is a regulator of apoptosis and is in a variety of cancers. Ki-67 is a proliferation marker. AND METHODS study of 98 ISCC of uterine cervix and 45 CIN cases was undertaken. Archived tissue blocks were retrieved subjected to Immunohistochemistry (IHC) for p53, Bcl-2 and Ki-67. Results were analysed for statistical significance. 26 cases belonged to stage IIIB & 18 to IIB i.e., higher stage of presentation was noted. 53% of CIN were HGCIN (CIN2+CIN3). Expression of Bcl-2 was higher in LGCIN (CIN1), as compared with HGCIN the difference in immunoexpression was highly significant statistically. Immunoexpression of Bcl-2 was higher in CIN (44.44%) as compared to ISCC (19.38%) and the difference was significant statistically. -67 immunoexpression showed an increasing trend with the progression of the disease (ISCC>HGCIN>LGCIN). was significant difference in immunoexpression of Bcl-2 in p53 negative and p53 positive ISCC cases. Thus, may suggest the p53 – Bcl-2 pathway of carcinogenesis in cervical cancer. -2 can be used to distinguish between LGCIN & HGCIN because there is a significant difference of Bcl-2 expression in two groups. Loss of Bcl-2 expression or absence of Bcl-2 expression could be used to predict invasion because there a significant difference in Bcl-2 expression in CIN and ISCC.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Barpande et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: